- Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis
-
Dohmen K, Onohara Sy, Harada S
- KMID: 2521497
- Korean J Gastroenterol.
- 2021 Oct;78(4):227-234.
- doi: 10.4166/kjg.2021.092
Background/Aims: The addition of a fibrate to ursodeoxycholic acid (UDCA) is the standard treatment for asymptomatic primary biliary cholangitis (aPBC) with an incomplete response to UDCA. Among the fibrates, bezafibrate... -
- CITED
-
- Close
- SHARE
-
- Close
